SCHEMBL472633

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL1575554	0.91	TDP1 (0.44)	TDP1POLBMAPTATMKDM4E
	SCHEMBL472654	0.88	CA1 (0.41)	TDP1POLBCA1CA2MAPT
	SCHEMBL472706	0.85	CA1 (0.32)	CA1CA2
	SCHEMBL472693	0.85	BACE1 (0.32)	CA1CA2
	SCHEMBL13299347	0.84	POLB (0.43)	TDP1POLBMAPTATMKDM4E
	SCHEMBL472677	0.84	CA1 (0.33)	CA1CA2HTT
	SCHEMBL10282198	0.83	CA1 (0.32)	CA1CA2
	SCHEMBL566263	0.83	CA1 (0.41)	TDP1POLBCA1CA2MAPT
	SCHEMBL472662	0.82	MAPT (0.42)	TDP1POLBCA1CA2MAPT
	SCHEMBL10155856	0.82	CA1 (0.43)	TDP1POLBCA1CA2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.